Now you know why I have referenced Fraunhofer and their annual reports so often. They were trying to shout this good news from the roof tops. The 17 missing SOC/placebo patients never had a good answer from the bears and Les could only pretend to know about randomization. Best wishes.
Thanks for the great work, that is good news :-) now I'm a little curious about If the FDA also accepted the changes? I would think that a PR would be a no brainer for such news .. even if they might be afraid that some would criticize these changes, it would be best to take these hits before TLD and not after ... but they may also be in doubt if the FDA has not agreed to change endpoints .. well exciting times .. and thanks again
Market Data 
Markets 
AI
